The case for PARITY

One summit. The full biosimilars equation.

Commercial outcomes demand more than a regulatory conversation. PARITY connects the people responsible for every decision between analytical similarity and patient access.

Why now

The market is moving from proof to performance.

A projected $176 billion global market by 2034. More than 90 US approvals across 20 molecules. A new wave of exclusivity loss ahead.

That growth creates a new set of pressures. Developers need reliable manufacturing and differentiated market-entry plans. CDMOs need visibility into the programs coming next. Payers, regulators, and providers need workable approaches to adoption. Investors need to see where science can become durable value.

PARITY puts those connected questions in the same room.

Our difference

Designed end to end around progress.

01

Commercial by design

Every track ties technical and regulatory insight back to launch, access, partnering, or portfolio decisions.

02

Deliberately concentrated

Target attendance of 180–220 keeps the room senior, relevant, and navigable.

03

Partnering with structure

Pre-event profiles, requested matches, and dedicated meeting time turn introductions into a working agenda.

Who attends

The people who can change the answer.

From early analytical strategy to formulary placement and licensing, every decision-making function has a place at PARITY.

  • 01Biosimilar developers and manufacturers building originator, pure-play, and emerging portfolios.
  • 02CDMOs and supply partners providing development, scale-up, technology transfer, and commercial capacity.
  • 03Market access and payer teams navigating pricing, reimbursement, substitution, and the Maximum Fair Price landscape.
  • 04Business development and licensing executives sourcing, assessing, and structuring partnerships.
  • 05Legal, IP, and regulatory leaders shaping freedom to operate, BPCIA strategy, and global submissions.
  • 06Investors, analysts, regulators, and policy makers tracking capital, evidence, and system-wide adoption.

The promise

Three days. One roof. Every stakeholder.

Come ready to test a strategy, find a partner, or place a bet on what comes next.

PARITY 2027 is produced by Synerg Events, organizers of NEURO-LOGIC, NULLIFY, and ADC NEXUS.